Activation of polyamine catabolism by N1, N11-diethylnorspermine alters the cellular localization of mTOR and downregulates mTOR protein level in glioblastoma cells

Rongcai Jiang, Woonyoung Choi, Limei Hu, Eugene W. Gerner, Stanley R. Hamilton, Wei Zhang

Research output: Contribution to journalArticle

Abstract

N1, N11-Diethylnorspermine (DENSPM) is a spermine analog and prototype anti-cancer drug that depletes cellular polyamine, increases cellular oxidative stress through the generation of H 2O2 and induces the death of multiple types of cancer cells. However, the survival pathways perturbed by DENSPM are uncertain. To identify these pathways, we examined a series of proteins in the phosphoinositide 3-kinase /AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) pathways in glioblastoma cell lines before and after treatment with DENSPM. We found that DENSPM did not change the protein levels of PI3K but did reduce the levels of AKT, phosphorylated AKT, mTOR, phosphorylated mTOR, p70S6K, phosphorylated p70S6K, 4E-BP1, phosphorylated 4E-BP1 and eIF-4B proteins. From this it appears that DENSPM directly targets the mTOR protein level in these glioblastoma cells by inhibiting mTOR-mediated protein synthesis. Immunofluorescence analysis of mTOR showed that DENSPM sequestered mTOR in the perinuclear region of the cells. We also detected a marked collapse of microtubules in U87 cells and a detachment of cells in a process resembling anoikis. We further showed that the levels of many proteins regulating cell growth and cell adhesion were downregulated, suggesting a broad effect of DENSPM on mTOR-mediated protein synthesis. We conclude that the activation of polyamine catabolism alters the cellular location of mTOR, thus negatively affecting mTOR-mediated protein synthesis and leading to the death of glioblastoma cells.

Original languageEnglish (US)
Pages (from-to)1644-1648
Number of pages5
JournalCancer Biology and Therapy
Volume6
Issue number10
DOIs
StatePublished - Jan 1 2007
Externally publishedYes

Fingerprint

TOR Serine-Threonine Kinases
Polyamines
Glioblastoma
Down-Regulation
70-kDa Ribosomal Protein S6 Kinases
Proteins
Anoikis
1-Phosphatidylinositol 4-Kinase
Spermine
Sirolimus
Phosphatidylinositol 3-Kinases
Cell Adhesion
Microtubules
Fluorescent Antibody Technique
Neoplasms
Oxidative Stress
Cell Death
Cell Line
Growth
Pharmaceutical Preparations

Keywords

  • DENSPM
  • Glioblastoma
  • mTOR
  • Polyamine

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Cite this

Activation of polyamine catabolism by N1, N11-diethylnorspermine alters the cellular localization of mTOR and downregulates mTOR protein level in glioblastoma cells. / Jiang, Rongcai; Choi, Woonyoung; Hu, Limei; Gerner, Eugene W.; Hamilton, Stanley R.; Zhang, Wei.

In: Cancer Biology and Therapy, Vol. 6, No. 10, 01.01.2007, p. 1644-1648.

Research output: Contribution to journalArticle

@article{a75b2807e9b84b0180466dd99d8a95a9,
title = "Activation of polyamine catabolism by N1, N11-diethylnorspermine alters the cellular localization of mTOR and downregulates mTOR protein level in glioblastoma cells",
abstract = "N1, N11-Diethylnorspermine (DENSPM) is a spermine analog and prototype anti-cancer drug that depletes cellular polyamine, increases cellular oxidative stress through the generation of H 2O2 and induces the death of multiple types of cancer cells. However, the survival pathways perturbed by DENSPM are uncertain. To identify these pathways, we examined a series of proteins in the phosphoinositide 3-kinase /AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) pathways in glioblastoma cell lines before and after treatment with DENSPM. We found that DENSPM did not change the protein levels of PI3K but did reduce the levels of AKT, phosphorylated AKT, mTOR, phosphorylated mTOR, p70S6K, phosphorylated p70S6K, 4E-BP1, phosphorylated 4E-BP1 and eIF-4B proteins. From this it appears that DENSPM directly targets the mTOR protein level in these glioblastoma cells by inhibiting mTOR-mediated protein synthesis. Immunofluorescence analysis of mTOR showed that DENSPM sequestered mTOR in the perinuclear region of the cells. We also detected a marked collapse of microtubules in U87 cells and a detachment of cells in a process resembling anoikis. We further showed that the levels of many proteins regulating cell growth and cell adhesion were downregulated, suggesting a broad effect of DENSPM on mTOR-mediated protein synthesis. We conclude that the activation of polyamine catabolism alters the cellular location of mTOR, thus negatively affecting mTOR-mediated protein synthesis and leading to the death of glioblastoma cells.",
keywords = "DENSPM, Glioblastoma, mTOR, Polyamine",
author = "Rongcai Jiang and Woonyoung Choi and Limei Hu and Gerner, {Eugene W.} and Hamilton, {Stanley R.} and Wei Zhang",
year = "2007",
month = "1",
day = "1",
doi = "10.4161/cbt.6.10.4800",
language = "English (US)",
volume = "6",
pages = "1644--1648",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "10",

}

TY - JOUR

T1 - Activation of polyamine catabolism by N1, N11-diethylnorspermine alters the cellular localization of mTOR and downregulates mTOR protein level in glioblastoma cells

AU - Jiang, Rongcai

AU - Choi, Woonyoung

AU - Hu, Limei

AU - Gerner, Eugene W.

AU - Hamilton, Stanley R.

AU - Zhang, Wei

PY - 2007/1/1

Y1 - 2007/1/1

N2 - N1, N11-Diethylnorspermine (DENSPM) is a spermine analog and prototype anti-cancer drug that depletes cellular polyamine, increases cellular oxidative stress through the generation of H 2O2 and induces the death of multiple types of cancer cells. However, the survival pathways perturbed by DENSPM are uncertain. To identify these pathways, we examined a series of proteins in the phosphoinositide 3-kinase /AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) pathways in glioblastoma cell lines before and after treatment with DENSPM. We found that DENSPM did not change the protein levels of PI3K but did reduce the levels of AKT, phosphorylated AKT, mTOR, phosphorylated mTOR, p70S6K, phosphorylated p70S6K, 4E-BP1, phosphorylated 4E-BP1 and eIF-4B proteins. From this it appears that DENSPM directly targets the mTOR protein level in these glioblastoma cells by inhibiting mTOR-mediated protein synthesis. Immunofluorescence analysis of mTOR showed that DENSPM sequestered mTOR in the perinuclear region of the cells. We also detected a marked collapse of microtubules in U87 cells and a detachment of cells in a process resembling anoikis. We further showed that the levels of many proteins regulating cell growth and cell adhesion were downregulated, suggesting a broad effect of DENSPM on mTOR-mediated protein synthesis. We conclude that the activation of polyamine catabolism alters the cellular location of mTOR, thus negatively affecting mTOR-mediated protein synthesis and leading to the death of glioblastoma cells.

AB - N1, N11-Diethylnorspermine (DENSPM) is a spermine analog and prototype anti-cancer drug that depletes cellular polyamine, increases cellular oxidative stress through the generation of H 2O2 and induces the death of multiple types of cancer cells. However, the survival pathways perturbed by DENSPM are uncertain. To identify these pathways, we examined a series of proteins in the phosphoinositide 3-kinase /AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) pathways in glioblastoma cell lines before and after treatment with DENSPM. We found that DENSPM did not change the protein levels of PI3K but did reduce the levels of AKT, phosphorylated AKT, mTOR, phosphorylated mTOR, p70S6K, phosphorylated p70S6K, 4E-BP1, phosphorylated 4E-BP1 and eIF-4B proteins. From this it appears that DENSPM directly targets the mTOR protein level in these glioblastoma cells by inhibiting mTOR-mediated protein synthesis. Immunofluorescence analysis of mTOR showed that DENSPM sequestered mTOR in the perinuclear region of the cells. We also detected a marked collapse of microtubules in U87 cells and a detachment of cells in a process resembling anoikis. We further showed that the levels of many proteins regulating cell growth and cell adhesion were downregulated, suggesting a broad effect of DENSPM on mTOR-mediated protein synthesis. We conclude that the activation of polyamine catabolism alters the cellular location of mTOR, thus negatively affecting mTOR-mediated protein synthesis and leading to the death of glioblastoma cells.

KW - DENSPM

KW - Glioblastoma

KW - mTOR

KW - Polyamine

UR - http://www.scopus.com/inward/record.url?scp=41649120239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41649120239&partnerID=8YFLogxK

U2 - 10.4161/cbt.6.10.4800

DO - 10.4161/cbt.6.10.4800

M3 - Article

C2 - 17921698

AN - SCOPUS:41649120239

VL - 6

SP - 1644

EP - 1648

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 10

ER -